O	O	0	1	A	A	B-NP	DT	O	3	NMOD	O
O	O	2	5	low	low	I-NP	JJ	O	3	NMOD	O
T1	B-Protein	6	10	NM23	NM23	I-NP	NN	B-protein	7	NMOD	B-protein
T1	I-Protein	10	11	.	.	I-NP	.	O	3	P	O
T1	I-Protein	11	13	H1	H1	I-NP	NN	B-DNA	7	NMOD	B-DNA
O	O	14	18	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	19	29	expression	expression	I-NP	NN	O	0	ROOT	O
O	O	30	41	identifying	identify	B-VP	VBG	O	7	NMOD	O
O	O	42	46	high	high	B-NP	JJ	O	12	NMOD	O
O	O	47	57	malignancy	malignancy	I-NP	NN	O	12	NMOD	O
O	O	58	63	human	human	I-NP	JJ	O	12	NMOD	O
O	O	64	73	melanomas	melanoma	I-NP	NNS	O	8	OBJ	O
O	O	73	74	.	.	O	.	O	7	P	O

O	O	76	79	The	The	B-NP	DT	O	3	NMOD	O
T3	B-Entity	80	84	NM23	NM23	I-NP	NN	B-DNA	3	NMOD	B-DNA
T3	I-Entity	85	89	gene	gene	I-NP	NN	I-DNA	4	SUB	I-DNA
O	O	90	93	has	have	B-VP	VBZ	O	17	VMOD	O
O	O	94	98	been	be	I-VP	VBN	O	4	VC	O
O	O	99	107	proposed	propose	I-VP	VBN	O	5	VC	O
O	O	108	110	as	as	B-PP	IN	O	6	VMOD	O
O	O	111	112	a	a	B-NP	DT	O	12	NMOD	O
T4	B-Entity	113	123	metastasis	metastasis	I-NP	NN	B-DNA	12	NMOD	B-DNA
T4	I-Entity	123	124	-	-	B-NP	HYPH	I-DNA	12	NMOD	I-DNA
T4	I-Entity	124	134	suppressor	suppressor	I-NP	NN	I-DNA	12	NMOD	I-DNA
T4	I-Entity	135	139	gene	gene	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	139	140	,	,	O	,	O	17	P	O
O	O	141	144	and	and	O	CC	O	17	VMOD	O
O	O	145	148	its	its	B-NP	PRP$	O	16	NMOD	O
O	O	149	152	use	use	I-NP	NN	O	17	SUB	O
O	O	153	156	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	157	161	been	be	I-VP	VBN	O	17	VC	O
O	O	162	171	suggested	suggest	I-VP	VBN	O	18	VC	O
O	O	172	174	as	as	B-PP	IN	O	19	VMOD	O
O	O	175	185	prognostic	prognostic	B-NP	JJ	B-protein	22	NMOD	B-protein
O	O	186	192	factor	factor	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	192	193	.	.	O	.	O	17	P	O

O	O	194	198	NM23	NM23	B-NP	NN	B-protein	2	SUB	B-protein
O	O	199	202	was	be	B-VP	VBD	O	0	ROOT	O
O	O	203	213	identified	identify	I-VP	VBN	O	2	VC	O
O	O	214	216	in	in	B-PP	IN	O	3	VMOD	O
O	O	217	218	a	a	B-NP	DT	O	6	NMOD	O
O	O	219	225	system	system	I-NP	NN	O	4	PMOD	O
O	O	226	228	of	of	B-PP	IN	O	6	NMOD	O
O	O	229	235	murine	murine	B-NP	JJ	B-cell_line	11	NMOD	B-cell_line
O	O	236	244	melanoma	melanoma	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	245	249	cell	cell	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	250	255	lines	line	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	255	256	,	,	O	,	O	11	P	O
O	O	257	259	in	in	B-PP	IN	O	11	NMOD	O
O	O	260	265	which	which	B-NP	WDT	O	13	PMOD	O
O	O	266	268	an	an	B-NP	DT	O	17	NMOD	O
O	O	269	276	inverse	inverse	I-NP	JJ	O	17	NMOD	O
O	O	277	289	relationship	relationship	I-NP	NN	O	18	SUB	O
O	O	290	293	was	be	B-VP	VBD	O	13	SBAR	O
O	O	294	299	found	find	I-VP	VBN	O	18	VC	O
O	O	300	307	between	between	B-PP	IN	O	19	VMOD	O
O	O	308	312	NM23	NM23	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	313	323	expression	expression	I-NP	NN	O	25	NMOD	O
O	O	324	327	and	and	O	CC	O	25	NMOD	O
O	O	328	338	metastatic	metastatic	B-NP	JJ	O	25	NMOD	O
O	O	339	346	ability	ability	I-NP	NN	O	20	PMOD	O
O	O	346	347	.	.	O	.	O	2	P	O

O	O	348	350	In	In	B-PP	IN	O	9	VMOD	O
O	O	351	352	a	a	B-NP	DT	O	6	NMOD	O
O	O	353	358	human	human	I-NP	JJ	O	6	NMOD	O
O	O	359	368	malignant	malignant	I-NP	JJ	O	6	NMOD	O
O	O	369	377	melanoma	melanoma	I-NP	NN	O	6	NMOD	O
O	O	378	383	study	study	I-NP	NN	O	1	PMOD	O
O	O	384	388	NM23	NM23	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	389	399	expression	expression	I-NP	NN	O	9	SUB	O
O	O	400	403	was	be	B-VP	VBD	O	0	ROOT	O
O	O	404	409	found	find	I-VP	VBN	O	9	VC	O
O	O	410	412	to	to	I-VP	TO	O	12	VMOD	O
O	O	413	415	be	be	I-VP	VB	O	10	VMOD	O
O	O	416	429	significantly	significantly	B-ADJP	RB	O	14	AMOD	O
O	O	430	435	lower	low	I-ADJP	JJR	O	12	PRD	O
O	O	436	438	in	in	B-PP	IN	O	14	AMOD	O
O	O	439	449	metastases	metastasis	B-NP	NNS	O	15	PMOD	O
O	O	450	454	that	that	B-NP	WDT	O	16	NMOD	O
O	O	455	464	developed	develop	B-VP	VBD	O	17	SBAR	O
O	O	465	469	less	less	B-NP	JJR	O	20	AMOD	O
O	O	470	474	than	than	I-NP	IN	O	22	NMOD	O
O	O	475	477	24	24	I-NP	CD	O	20	AMOD	O
O	O	478	484	months	month	I-NP	NNS	O	23	PMOD	O
O	O	485	490	after	after	B-PP	IN	O	18	VMOD	O
O	O	491	500	diagnosis	diagnosis	B-NP	NN	O	23	PMOD	O
O	O	501	503	of	of	B-PP	IN	O	24	NMOD	O
O	O	504	507	the	the	B-NP	DT	O	28	NMOD	O
O	O	508	515	primary	primary	I-NP	JJ	B-cell_type	28	NMOD	B-cell_type
O	O	516	523	tumours	tumour	I-NP	NNS	I-cell_type	25	PMOD	I-cell_type
O	O	523	524	.	.	O	.	O	9	P	O

O	O	525	528	The	The	B-NP	DT	O	3	NMOD	O
O	O	529	536	present	present	I-NP	JJ	O	3	NMOD	O
O	O	537	542	paper	paper	I-NP	NN	O	4	SUB	O
O	O	543	550	studies	study	I-NP	NNS	O	0	ROOT	O
O	O	551	554	the	the	B-NP	DT	O	6	NMOD	O
O	O	555	565	expression	expression	I-NP	NN	O	4	OBJ	O
O	O	566	568	of	of	B-PP	IN	O	6	NMOD	O
O	O	569	572	the	the	B-NP	DT	O	12	NMOD	O
T2	B-Protein	573	577	NM23	NM23	I-NP	NN	B-DNA	12	NMOD	B-DNA
T2	I-Protein	577	578	.	.	I-NP	.	I-DNA	12	NMOD	I-DNA
T2	I-Protein	578	580	H1	H1	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	581	585	gene	gene	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	586	588	in	in	B-PP	IN	O	6	NMOD	O
O	O	589	593	cell	cell	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	594	599	lines	line	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	600	605	which	which	B-NP	WDT	O	15	NMOD	O
O	O	606	612	derive	derive	B-VP	VBP	O	16	SBAR	O
O	O	613	617	from	from	B-PP	IN	O	17	VMOD	O
O	O	618	625	primary	primary	B-NP	JJ	O	24	NMOD	O
O	O	626	628	or	or	I-NP	CC	O	24	NMOD	O
O	O	629	639	metastatic	metastatic	I-NP	JJ	O	24	NMOD	O
O	O	640	645	human	human	I-NP	JJ	O	24	NMOD	O
O	O	646	655	malignant	malignant	I-NP	JJ	O	24	NMOD	O
O	O	656	665	melanomas	melanoma	I-NP	NNS	O	18	PMOD	O
O	O	666	668	in	in	B-PP	IN	O	4	NMOD	O
O	O	669	677	relation	relation	B-NP	NN	O	25	PMOD	O
O	O	678	680	to	to	B-PP	TO	O	26	NMOD	O
O	O	681	688	staging	staging	B-NP	NN	O	48	NMOD	O
O	O	688	689	,	,	O	,	O	48	P	O
O	O	690	702	infiltration	infiltration	B-NP	NN	O	31	NMOD	O
O	O	703	709	degree	degree	I-NP	NN	O	48	NMOD	O
O	O	709	710	,	,	O	,	O	48	P	O
O	O	711	722	lymphocytic	lymphocytic	B-NP	JJ	O	34	NMOD	O
O	O	723	735	infiltration	infiltration	I-NP	NN	O	48	NMOD	O
O	O	735	736	,	,	O	,	O	48	P	O
O	O	737	741	cell	cell	B-NP	NN	O	37	NMOD	O
O	O	742	752	morphology	morphology	I-NP	NN	O	48	NMOD	O
O	O	752	753	,	,	O	,	O	48	P	O
O	O	754	758	cell	cell	B-NP	NN	O	40	NMOD	O
O	O	759	771	pigmentation	pigmentation	I-NP	NN	O	48	NMOD	O
O	O	771	772	,	,	O	,	O	48	P	O
O	O	773	782	karyotype	karyotype	B-NP	NN	O	48	NMOD	O
O	O	782	783	,	,	O	,	O	48	P	O
O	O	784	787	and	and	O	CC	O	48	NMOD	O
O	O	788	795	disease	disease	B-NP	NN	O	48	NMOD	O
O	O	795	796	-	-	O	HYPH	O	48	NMOD	O
O	O	796	800	free	free	B-NP	JJ	O	48	NMOD	O
O	O	801	809	survival	survival	I-NP	NN	O	27	PMOD	O
O	O	809	810	.	.	O	.	O	4	P	O

O	O	811	814	The	The	B-NP	DT	O	2	NMOD	O
O	O	815	820	level	level	I-NP	NN	O	10	SUB	O
O	O	821	823	of	of	B-PP	IN	O	2	NMOD	O
O	O	824	828	mRNA	mRNA	B-NP	NN	B-RNA	5	NMOD	B-RNA
O	O	829	839	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	840	842	of	of	B-PP	IN	O	5	NMOD	O
O	O	843	846	the	the	B-NP	DT	O	9	NMOD	O
T5	B-Entity	847	851	NM23	NM23	I-NP	NN	B-DNA	9	NMOD	B-DNA
T5	I-Entity	852	856	gene	gene	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	857	859	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	860	873	significantly	significantly	B-ADJP	RB	O	12	AMOD	O
O	O	874	879	lower	low	I-ADJP	JJR	O	10	PRD	O
O	O	880	882	in	in	B-PP	IN	O	12	AMOD	O
O	O	883	887	cell	cell	B-NP	NN	B-cell_line	15	NMOD	B-cell_line
O	O	888	893	lines	line	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	894	898	that	that	B-NP	WDT	O	15	NMOD	O
O	O	899	905	derive	derive	B-VP	VBP	O	16	SBAR	O
O	O	906	910	from	from	B-PP	IN	O	17	VMOD	O
O	O	911	915	more	more	B-NP	RBR	O	20	AMOD	O
O	O	916	928	infiltrating	infiltrate	B-VP	VBG	O	22	NMOD	O
O	O	929	936	primary	primary	B-NP	JJ	O	22	NMOD	O
O	O	937	946	melanomas	melanoma	I-NP	NNS	O	18	PMOD	O
O	O	947	951	than	than	B-PP	IN	O	12	AMOD	O
O	O	952	954	in	in	B-PP	IN	O	23	PMOD	O
O	O	955	959	cell	cell	B-NP	NN	B-cell_line	26	NMOD	B-cell_line
O	O	960	965	lines	line	I-NP	NNS	I-cell_line	24	PMOD	I-cell_line
O	O	966	974	obtained	obtain	B-VP	VBN	O	26	NMOD	O
O	O	975	979	from	from	B-PP	IN	O	27	VMOD	O
O	O	980	984	less	less	B-NP	JJR	O	30	AMOD	O
O	O	985	997	infiltrating	infiltrating	I-NP	JJ	O	31	NMOD	O
O	O	998	1005	tumours	tumour	I-NP	NNS	O	28	PMOD	O
O	O	1005	1006	.	.	O	.	O	10	P	O

O	O	1007	1015	Moreover	Moreover	B-ADVP	RB	O	27	VMOD	O
O	O	1015	1016	,	,	O	,	O	27	P	O
O	O	1017	1021	cell	cell	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	1022	1027	lines	line	I-NP	NNS	I-cell_line	27	SUB	I-cell_line
O	O	1028	1035	derived	derive	B-VP	VBN	O	4	NMOD	O
O	O	1036	1040	from	from	B-PP	IN	O	5	VMOD	O
O	O	1041	1048	tumours	tumour	B-NP	NNS	O	6	PMOD	O
O	O	1049	1051	of	of	B-PP	IN	O	7	NMOD	O
O	O	1052	1060	patients	patient	B-NP	NNS	O	8	PMOD	O
O	O	1061	1065	with	with	B-PP	IN	O	9	NMOD	O
O	O	1066	1067	a	a	B-NP	DT	O	15	NMOD	O
O	O	1068	1075	disease	disease	I-NP	NN	O	15	NMOD	O
O	O	1075	1076	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	1076	1080	free	free	I-NP	JJ	O	15	NMOD	O
O	O	1081	1089	survival	survival	I-NP	NN	O	10	PMOD	O
O	O	1090	1092	of	of	B-PP	IN	O	15	NMOD	O
O	O	1093	1097	more	more	B-NP	JJR	O	18	AMOD	O
O	O	1098	1102	than	than	I-NP	IN	O	20	NMOD	O
O	O	1103	1105	24	24	I-NP	CD	O	18	AMOD	O
O	O	1106	1112	months	month	I-NP	NNS	O	16	PMOD	O
O	O	1113	1114	(	(	O	(	O	26	DEP	O
O	O	1114	1116	24	24	B-NP	CD	O	25	NMOD	O
O	O	1116	1117	-	-	I-NP	HYPH	O	25	P	O
O	O	1117	1119	58	58	I-NP	CD	O	25	NMOD	O
O	O	1120	1126	months	month	I-NP	NNS	O	26	DEP	O
O	O	1126	1127	)	)	O	)	O	9	NMOD	O
O	O	1128	1135	express	express	B-VP	VBP	O	0	ROOT	O
O	O	1136	1139	the	the	B-NP	DT	O	30	NMOD	O
T6	B-Entity	1140	1144	NM23	NM23	I-NP	NN	B-DNA	30	NMOD	B-DNA
T6	I-Entity	1145	1149	gene	gene	I-NP	NN	I-DNA	27	OBJ	I-DNA
O	O	1150	1152	at	at	B-PP	IN	O	27	VMOD	O
O	O	1153	1159	higher	high	B-NP	JJR	O	33	NMOD	O
O	O	1160	1166	levels	level	I-NP	NNS	O	31	PMOD	O
O	O	1167	1171	than	than	B-PP	IN	O	33	NMOD	O
O	O	1172	1176	cell	cell	B-NP	NN	B-cell_line	36	NMOD	B-cell_line
O	O	1177	1182	lines	line	I-NP	NNS	I-cell_line	34	PMOD	I-cell_line
O	O	1183	1191	obtained	obtain	B-VP	VBN	O	36	NMOD	O
O	O	1192	1196	from	from	B-PP	IN	O	37	VMOD	O
O	O	1197	1206	melanomas	melanoma	B-NP	NNS	O	38	PMOD	O
O	O	1207	1209	of	of	B-PP	IN	O	39	NMOD	O
O	O	1210	1218	patients	patient	B-NP	NNS	O	40	PMOD	O
O	O	1219	1223	with	with	B-PP	IN	O	41	NMOD	O
O	O	1224	1225	a	a	B-NP	DT	O	47	NMOD	O
O	O	1226	1233	disease	disease	I-NP	NN	O	47	NMOD	O
O	O	1233	1234	-	-	B-NP	HYPH	O	47	NMOD	O
O	O	1234	1238	free	free	I-NP	JJ	O	47	NMOD	O
O	O	1239	1247	survival	survival	I-NP	NN	O	42	PMOD	O
O	O	1248	1250	of	of	B-PP	IN	O	47	NMOD	O
O	O	1251	1255	less	less	B-NP	JJR	O	50	AMOD	O
O	O	1256	1260	than	than	I-NP	IN	O	52	NMOD	O
O	O	1261	1263	24	24	I-NP	CD	O	50	AMOD	O
O	O	1264	1270	months	month	I-NP	NNS	O	48	PMOD	O
O	O	1271	1272	(	(	O	(	O	58	DEP	O
O	O	1272	1273	6	6	B-NP	CD	O	57	NMOD	O
O	O	1273	1274	-	-	I-NP	HYPH	O	57	NMOD	O
O	O	1274	1276	15	15	I-NP	CD	O	57	NMOD	O
O	O	1277	1283	months	month	I-NP	NNS	O	58	DEP	O
O	O	1283	1284	)	)	O	)	O	52	NMOD	O
O	O	1284	1285	.	.	O	.	O	27	P	O
